Log In
Print
BCIQ
Print
Print this Print this
 

Buccolam, midazolam

  Manage Alerts
Collapse Summary General Information
Company Shire plc
DescriptionOral formulaition of midazolam for buccal delivery
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationSeizures
Indication DetailsTreat prolonged, acute, convulsive seizures in patients 3 months to <18 years
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today